This treatment promotes functional recovery in rats following complete spinal cord transection, significantly upregulating the expression of GPX4 and FTH1, while downregulating ACSL4 and COX2 expression, suggesting its potential to modulate anti-ferroptosis pathways involved in SCI recovery (Wang J
(PubMed) Lombard KA, Olson AL, Nelson SE, Rebouche CJ
Last reviewed: May 18, 2026 Last updated: May 18, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Skip when you want
Consultas Mdicas : Consulta a un profesional de la salud antes de iniciar este suplemento si ests tomando medicamentos o tienes alguna condicin de salud preexistente